Youth Substance Use in the US: 2022 Report

Jan.03.2023
Youth Substance Use in the US: 2022 Report
American teenage drug use remains stable after a sharp decline in 2021 due to COVID-19 school closures and social distancing.

According to the latest report from a monitoring and survey agency in the United States, which assesses illegal substance use and associated attitudes in 8th, 10th, and 12th grade students, the proportion of American teenagers using illegal substances remained relatively stable in 2022 following a significant decrease in 2021. Almost all substances reported a decrease in usage from 2020 to 2021, likely due to the COVID-19 pandemic and related changes such as school closures and social distancing.


By 2022, it is expected that all grade levels mentioned in the report will maintain or demonstrate a substantial decrease in the use of illegal substances within the past year. Currently, 11% of eighth graders, 21.5% of tenth graders, and 32.6% of twelfth graders reported using illegal drugs within the past year.


The Monitoring the Future survey is conducted annually by researchers from the University of Michigan in Ann Arbor and is funded by the National Institute on Drug Abuse, which is a part of the National Institutes of Health.


A recent study found that alcohol, nicotine e-cigarettes, and marijuana are the most commonly reported substances used by teenagers in the past year, with levels remaining relatively stable compared to 2021. While there were some substances that showed an increase in reported usage from the previous year, the majority of reported usage levels remained the same or lower than pre-pandemic levels in 2020. When compared to levels observed in 2021, data reported in 2022 shows:


Nicotine electronic cigarettes remain stable among all three grades, with 12% of eighth graders, 20.5% of tenth graders, and 27.3% of twelfth graders reporting the use of nicotine in the past year.


The results of the survey indicate that the prevalence of cannabis use among students in grades eight, ten, and twelve has remained stable. 8.3% of eighth-grade students, 19.5% of tenth-grade students, and 30.7% of twelfth-grade students reported using cannabis in the past year. It is noteworthy that 6% of eighth-grade students, 15% of tenth-grade students, and 20.6% of twelfth-grade students reported smoking cannabis in the past year, indicating that the prevalence among eighth and twelfth-grade students has remained stable while there has been a slight increase in reported cannabis use among tenth-grade students, although the 2022 figures for tenth-graders are significantly lower than pre-pandemic levels.


The rate of alcohol consumption among eighth and tenth grade students remained steady (with 15.2% and 31.3% respectively reporting drinking in the past year), but the rate among twelfth grade students has returned to pre-pandemic levels (with 51.9% of twelfth graders reporting drinking in the past year in 2022).


According to a survey, the use of any illegal drugs other than marijuana has remained stable among all three grades surveyed. 4.9% of eighth-grade students, 5.7% of tenth-grade students, and 8% of twelfth-grade students reported using any illegal drugs other than marijuana in the past year. These data are based on long-term trends that show relatively low and stable levels of illicit substance use among adolescents, including the use of cocaine, heroin, amphetamines, and non-medical use of prescription drugs over the past year.


During the period of 2021 to 2022, there was a slight increase in the number of 12th grade students using anesthesia other than heroin, including Vicodin, OxyContin and Percocet (1.7% of 12th grade students reported using these drugs in the past year). This level remained consistent with pre-pandemic observations in 2019 and 2020 (2.7% and 2.1% respectively).



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK Prime Minister Andy Burnham’s government is adjusting business rates policy to support hospitality businesses while some other sectors, including vape retailers, face higher operating cost pressures. According to Streamline Feed, AJ Bell and other reports, the policy shift reflects a redistribution of business rate burdens as the government seeks to support sectors facing economic pressure. For UK vape shops, the change comes amid a broader regulatory environment shaped by the disposable vape ban, the upcoming Vaping Products Duty and increased compliance requirements.
News
Jul.24
UAE Sets Dh1-Per-ml Minimum Excise Price for Vape Liquids From Sept. 1 While Keeping 100% Tax Rate
UAE Sets Dh1-Per-ml Minimum Excise Price for Vape Liquids From Sept. 1 While Keeping 100% Tax Rate
The UAE Ministry of Finance will introduce a minimum excise price for e-liquids used in vaping and electronic smoking devices from September 1, 2026. The minimum excise price will be set at AED 1 per millilitre. The existing 100% excise tax rate will continue to apply to tobacco and electronic smoking products. The measure changes the minimum taxable base rather than the tax rate, with the UAE government saying it aims to establish unified tax standards, improve market compliance and prevent pricing loopholes.
Regulations
Aug.07 by 2Firsts Perspectives
Product | YOOZ Launches Waker Electronic Shisha Device, Expanding Vape Applications Beyond Portable Devices
Product | YOOZ Launches Waker Electronic Shisha Device, Expanding Vape Applications Beyond Portable Devices
YOOZ has introduced the Waker Electronic Shisha device, expanding its vaping portfolio into the electronic shisha category. The device combines a rechargeable hardware platform with dedicated cartridges, featuring a 4,000mAh battery, up to 60W output power, and LED lighting effects. The product has appeared across multiple French retail channels, reflecting the continued expansion of vaping products into new consumption scenarios.
Jul.13
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.
Aug.06